Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | HTR7 | P34969 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4994241 | 0.83 | LMNA (0.57) | LMNAL3MBTL1SMN1; SMN2USP2NPC1 | |
| SCHEMBL4996073 | 0.83 | LMNA (0.52) | LMNAL3MBTL1SMN1; SMN2USP2NPC1 | |
| SCHEMBL4992085 | 0.83 | MAPT (0.52) | LMNASMN1; SMN2NPC1ALDH1A1MAPT | |
| SCHEMBL4997044 | 0.83 | HTR7 (0.46) | L3MBTL1SMN1; SMN2HTR7NPC1RAB9A | |
| SCHEMBL4996849 | 0.82 | LMNA (0.53) | LMNAL3MBTL1SMN1; SMN2USP2HTR7 | |
| SCHEMBL4987386 | 0.81 | MAPT (0.57) | LMNAL3MBTL1SMN1; SMN2USP2NPC1 | |
| SCHEMBL4987426 | 0.81 | LMNA (0.57) | LMNAL3MBTL1SMN1; SMN2USP2NPC1 | |
| SCHEMBL4997644 | 0.80 | LMNA (0.56) | LMNAL3MBTL1SMN1; SMN2USP2HTR7 | |
| SCHEMBL4997526 | 0.80 | CYP11B2 (0.51) | LMNASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL4997627 | 0.79 | NPC1 (0.55) | LMNAL3MBTL1SMN1; SMN2USP2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080194574-A1 | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases | AXXIMA PHARMACEUTICALS AG (DE) | 2008-08-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194574-A1 | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases | PRNP, PSEN1, PPP5C | LMNA 2743/4885L3MBTL1 4837/4885SMN1; SMN2 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.